Kevin H. Roche

This profile gathers the share dealings of Kevin H. Roche across 4 companies, led by Tactile Systems Technology Inc, Uroplasty Inc and Cogentix Medical Inc /DE/. We count 63 filings; the first trade dates from 13 May 2010 and the latest from 1 October 2021.

The open-market side counts 30 purchases for €124k alongside 17 sales for €5.6M. The net balance comes to €5.4M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 9 share grants and 3 option exercises.

A typical purchase (the median) is worth €1,813.

Most recently, on 5 October 2021, the filings show an option exercise worth €120k in Tactile Systems Technology Inc. The last insider purchase was made public on 22 May 2015, 4,173 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.